8-O-Acetylharpagide

CAS No. 6926-14-3

8-O-Acetylharpagide( —— )

Catalog No. M19005 CAS No. 6926-14-3

8-O-Acetylharpagide has a biological activity on isolated smooth muscle preparations from guinea pig.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 38 In Stock
10MG 53 In Stock
25MG 93 In Stock
50MG 137 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    8-O-Acetylharpagide
  • Note
    Research use only, not for human use.
  • Brief Description
    8-O-Acetylharpagide has a biological activity on isolated smooth muscle preparations from guinea pig.
  • Description
    8-O-Acetylharpagide has anti-inflammatory activity. 8-O-Acetylharpagide has antibacteria and antiviral activities. 8-O-Acetylharpagide has a biological activity on isolated smooth muscle preparations from guinea pig.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    antibacterial
  • Research Area
    Infection|Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    6926-14-3
  • Formula Weight
    406.38
  • Molecular Formula
    C17H26O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (61.52 mM)
  • SMILES
    CC(=O)OC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rhodojaponin II

    Rhodojaponin II correlates pretty well with cardiotoxicity.

  • NCGC00135472

    NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.

  • Leucokinin IV

    Leucokinin IV